• Most MedTech organisations treat clinical literature as a project input rather than a shared asset
• Evidence gets rebuilt from scratch each CER cycle, stays locked in one person’s spreadsheet, and never reaches the R&D or Quality teams who need it most.
• Structured evidence infrastructure turns literature into a queryable, reusable knowledge base that serves Regulatory Affairs, Clinical Affairs, R&D, and Quality from a single source of truth.
• To break the silo, you need to prove benefits and return on investment every step of the way: efficiency & quality gains in clinical teams are the start